Brent MacGregor
Chief Executive Officer chez MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Fortune : - $ au 31/03/2024
Profil
Brent MacGregor is currently the Chief Executive Officer at Medical Developments International Ltd.
and an Independent Director at Dynavax Technologies Corp.
He previously held positions as the Chief Executive Officer-Influenza Vaccine at Novartis AG, Executive Director-Global Strategic Planning at Sanofi, and Senior Vice President-Global Commercial Operations at Seqirus USA, Inc. Mr. MacGregor has a graduate degree from The University of Reading, an undergraduate degree from Carleton University, and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Brent MacGregor
| Sociétés | Poste | Début |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Director/Board Member | 17/07/2020 |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Chief Executive Officer | 01/11/2020 |
Anciens postes connus de Brent MacGregor
| Sociétés | Poste | Fin |
|---|---|---|
| Seqirus USA, Inc. | Corporate Officer/Principal | 01/06/2020 |
| SANOFI | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de Brent MacGregor
| The University of Reading | Graduate Degree |
| Carleton University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| SANOFI | Health Technology |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Seqirus USA, Inc. |
